Viewpoints

Aug 02, 2017
Pharmaceutical Technology
Amid contentious debate about “fake news,” peer-review papers offer vital, objective insight.
Aug 02, 2017
Pharmaceutical Technology
The review of batch records creates a story of the materials, manufacturing, and packaging involved in the production of bio/pharmaceuticals, according to Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
Jun 05, 2017
The author shares his opinion on the challenges presented by the Internet of Things and what companies need to consider when choosing suitable architectures to manage serialization data.
Jun 02, 2017
Pharmaceutical Technology
New reports indicate that drug prices are slowing compared to other healthcare costs.
Jun 02, 2017
Pharmaceutical Technology
Informing your clients of possible changes in equipment is imperative when upgrading a laboratory, says Susan Schniepp, distinguished fellow at Regulatory Compliance Associates.
May 08, 2017
Biomedical researcher shares insights from a career dedicated to advancing therapeutic innovations for unmet medical needs.
May 02, 2017
Pharmaceutical Technology
By Pharmaceutical Technology Editors
Siegfried Schmitt, PhD, Principal Consultant at PAREXEL, discusses how to gain benefits from interactions with industry associations.
Apr 02, 2017
Pharmaceutical Technology
Susan Schniepp, distinguished fellow at Regulatory Compliance Associates, discusses the value of internal audits and how the information gained can be applied.
Mar 02, 2017
Pharmaceutical Technology
Drug type, potential sales, and ownership factor in the race to get drugs to market.
Mar 02, 2017
Pharmaceutical Technology
Siegfried Schmitt, PhD, Principal Consultant at PAREXEL, discusses how to mitigate risk in a global regulatory environment.
native1_300x100
lorem ipsum